Biocompatibility screening of poly (vinyl chloride) implants

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Biochemistry

Background:

• Assessing the biocompatibility of medical implants is crucial for patient safety.
• Enzyme activity in surrounding tissues can indicate a material's biological response.
• Poly(vinyl chloride) (PVC) is a common polymer used in medical devices.

Purpose of the Study:

• To evaluate the biocompatibility of medical-grade poly(vinyl chloride) (PVC) implants.
• To investigate changes in specific enzyme activities in rat muscle tissue following PVC implantation.

Main Methods:

• Medical-grade PVC was implanted into rat gluteal muscles.
• Muscle tissue samples were collected at 7, 14, and 21 days post-implantation.
• Activities of alkaline phosphatase, acid phosphatase, Ca2+ ATPase, leucine aminopeptidase (LAP), and succinic dehydrogenase (SDH) were measured in tissue homogenates.

Main Results:

• Implanted sites showed increased activity of acid phosphatase, alkaline phosphatase, LAP, and Ca2+ ATPase compared to non-implanted sites.
• Succinic dehydrogenase (SDH) activity was reduced at the implanted site.
• Peak enzyme alterations occurred around 14 days, with alkaline phosphatase and acid phosphatase showing the most significant increase.
• Enzyme activity changes gradually decreased after 21 days.

Conclusions:

• Medical-grade PVC elicits a localized inflammatory and metabolic response in rat muscle tissue.
• The observed enzyme activity changes suggest cellular stress and altered metabolic function around the implant.
• Enzyme assays provide a sensitive method for assessing implant biocompatibility and host tissue response.